Study Title. Set-Up and Pre-Validation of an HPLC Method for the Determination of BA058 and PTH in Dose Formulations SCOPE OF WORK DATED: November 14, 2008 PRICE: $1,900 US/Day (as per Study Authorization dated February 9, 2009) [*] % MPM discount included PAYMENT TERMS: · Monthly billing as per work performed. PROPOSED COMMENCEMENT OF WORK: February 2009 PROPOSED REPORTING TIME: Not applicable ACCLIMATION PERIOD: Not applicable RETENTION PERIOD: One (1) year STUDY MATERIAL STORAGE/ARCHIVES. After dispatch of the draft report, all raw data, samples/specimens (except for those sent to Sponsor or Sponsor designated laboratory and resultant data which are the responsibility of Sponsor) and documents generated at Xxxxxxx River Montreal during this study, together with the original copy of the protocol (including amendments) and the draft report, will be retained in the secure storage area of Xxxxxxx River Montreal for one (1) year at no charge. After this one (1’) year period, Sponsor will be contacted prior to the end of the year to authorize continued storage or return to Sponsor, at additional cost. At finalisation, the final report and any stored materials will be transferred to the scientific archives of Xxxxxxx River Montreal. Subsequently, storage details will be documented in the raw data. Any additional storage, archiving or retention will require an Extended Archiving Agreement DELAY IN PRECLINICAL WORK. In the event that any animals are purchased by Xxxxxxx River Montreal, as authorized by and on behalf of the Sponsor, for preclinical work to be performed under this Letter of Agreement, the parties hereto agree that the acclimation period (“Acclimation Period”) shall be stipulated herein. After the completion of the Acclimation Period, should there be any delay in the commencement of the Study that is attributable to the Sponsor, in any way, then the Sponsor agrees to reimburse housing fees to Xxxxxxx River Montreal for the said delay at rates prevailing at the time of said delay.
Study Title. [Insert SHORT TITLE OF STUDY] Reference: [Insert REFERENCE NUMBER e.g. IRAS, EUDRACT NUMBER OR SIMILAR REFERENCE]
Study Title. Validation of an HPLC Method for the Determination of BA058 and PTH in Dose Formulations SCOPE OF WORK DATED: To be provided PRICE: $21,850 US (as per Study Authorization dated February 9, 2009) [*] % [*] discount included PAYMENT TERMS: 50% - $10,925 US - 1st installment at commencement of laboratory work 50% - $10,925 US - 2nd installment at completion of laboratory work (excluding long term stability testing, if applicable) PROPOSED COMMENCEMENT OF WORK: March 2009
Examples of Study Title in a sentence
Study Title) of the Requirements Status and Registrant's Response form.
Include the Study Title This study has been explained to me and any questions I had have been answered.
Protocol No. Study Title : Name of Principal Investigator : Type of COI (Personal/ Professional/Financial) and the Reason : Hence, I stay away from reviewing this research proposal, any deliberations/discussions on this study, and refrain from any decision making.
Study Title: (The title should accurately reflect the purpose of the study.
Case Study Title (Case Study):Case Study #1, Alpine Ski HouseOverviewAlpine Ski House operates ski resorts that provide accommodations, dining, and entertainment to customers.The company recently acquired four resorts from Contoso, Ltd.
More Definitions of Study Title
Study Title. IRB #: The above-named Unaffiliated Investigator has reviewed the Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research; the U.S. Department of Health and Human Services (DHHS) regulations for the protection of human subjects at 45 CFR 46, the Assurance referenced above, and the relevant institutional policies and procedures for the protection of human subjects.
Study Title. Screen hENT1 antibody for suitability on Ventana’s automated system. • Study Identification: Clovis hENT1 BIOMARKER PROJECT
Study Title. [TITLE] [SPONSOR_PROTOCOLS] This confirms that an IRB Authorization Agreement with the organization identified above has been executed to rely on their IRB for continuing oversight of this study. This agreement specifies the roles and responsibilities of the respective entities. [DESCRIPTION] [SUBMISSION_DESCRIPTION] [FINDINGS] It is your responsibility to: SAMPLE ONLY
Study Title. A Phase 1b/2, Open-Label, Název klinického hodnocení: „Otevřená Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3XCD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter’s Syndrome Protocol no.: GCT3013-03 studie fáze 1b/2 hodnotící bezpečnost a účinnost přípravku epcoritamab (GEN3013; DuoBody®-CD3 X CD20) u pacientů s relabující/refrakterní chronickou lymfocytickou leukémií a Richterovým syndromem” Č. protokolu: GCT3013-03
Study Title. Lung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema (Clinical Protocol 630-0012).
Study Title. A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects with Hypertension Requiring Antihypertensive Therapy PROTOCOL NO.: K-302-03-01 PROPOSED ALLOCATION OF SPONSOR - JAVA- DUTIES AND FUNCTIONS 04 FEBRUARY 2014 I. Regulatory and Ethics II. Investigator Relations III. IMP Supplies IV. Study Documentation
Study Title. [*] PRINCIPAL INVESTIGATOR: Robexx Xxxxxxxx, X.D. ADDRESS: IMTCI 16300 Xxxxxxx Xxxxxxxxx Xxxxxx, Xxxxxx, XXX 00000 XXLEPHONE NUMBER: 913-599-4100 SUB-INVESTIGATORS: Rod Xxxxxxxx, Xx.D.